Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Cryptogenic stroke and patent foramen ovale : S2e guidelines].

Literature DB >> 30255469

[Cryptogenic stroke and patent foramen ovale : S2e guidelines].

Hans-Christoph Diener¹, Armin J Grau², Stephan Baldus³, Alexander Ghanem⁴, Klaus Gröschel⁵, Christoph Liebetrau⁶, Steffen Massberg⁷, Helge Möllmann⁸, Holger Nef⁹, Dirk Sander¹⁰, Christian Weimar¹¹, Jochen Wöhrle¹², Heinrich Mattle¹³.

Abstract

Entities: Disease

Mesh：

Year: 2018 PMID： 30255469 DOI： 10.1007/s00115-018-0609-y

Source DB: PubMed Journal: Nervenarzt ISSN： 0028-2804 Impact factor: 1.214

× No keyword cloud information.

23 in total

1. Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis.

Authors: Rahman Shah; Mannu Nayyar; Ion S Jovin; Abdul Rashid; Beatrix R Bondy; Tai-Hwang M Fan; Michael P Flaherty; Sunil V Rao
Journal: Ann Intern Med Date: 2018-01-09 Impact factor: 25.391

2. Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials.

Authors: Elsayed Abo-Salem; Bernard Chaitman; Tarek Helmy; Eric Adjei Boakye; Hassan Alkhawam; Michael Lim
Journal: J Neurol Date: 2018-01-22 Impact factor: 4.849

3. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Authors: Jean-Louis Mas; Geneviève Derumeaux; Benoît Guillon; Evelyne Massardier; Hassan Hosseini; Laura Mechtouff; Caroline Arquizan; Yannick Béjot; Fabrice Vuillier; Olivier Detante; Céline Guidoux; Sandrine Canaple; Claudia Vaduva; Nelly Dequatre-Ponchelle; Igor Sibon; Pierre Garnier; Anna Ferrier; Serge Timsit; Emmanuelle Robinet-Borgomano; Denis Sablot; Jean-Christophe Lacour; Mathieu Zuber; Pascal Favrole; Jean-François Pinel; Marion Apoil; Peggy Reiner; Catherine Lefebvre; Patrice Guérin; Christophe Piot; Roland Rossi; Jean-Luc Dubois-Randé; Jean-Christophe Eicher; Nicolas Meneveau; Jean-René Lusson; Bernard Bertrand; Jean-Marc Schleich; François Godart; Jean-Benoit Thambo; Laurent Leborgne; Patrik Michel; Luc Pierard; Guillaume Turc; Martine Barthelet; Anaïs Charles-Nelson; Christian Weimar; Thierry Moulin; Jean-Michel Juliard; Gilles Chatellier
Journal: N Engl J Med Date: 2017-09-14 Impact factor: 91.245

4. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors: Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal: N Engl J Med Date: 2017-09-14 Impact factor: 91.245

Review 5. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.

Authors: George Ntaios; Vasileios Papavasileiou; Dimitrios Sagris; Konstantinos Makaritsis; Konstantinos Vemmos; Thorsten Steiner; Patrik Michel
Journal: Stroke Date: 2018-01-15 Impact factor: 7.914

6. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Authors: John D Carroll; Jeffrey L Saver; David E Thaler; Richard W Smalling; Scott Berry; Lee A MacDonald; David S Marks; David L Tirschwell
Journal: N Engl J Med Date: 2013-03-21 Impact factor: 91.245

7. Embolic strokes of undetermined source: the case for a new clinical construct.

Authors: Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal: Lancet Neurol Date: 2014-04 Impact factor: 44.182

8. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.

Authors: Yousif Ahmad; James P Howard; Ahran Arnold; Matthew Shun Shin; Christopher Cook; Ricardo Petraco; Ozan Demir; Luke Williams; Juan F Iglesias; Nilesh Sutaria; Iqbal Malik; Justin Davies; Jamil Mayet; Darrel Francis; Sayan Sen
Journal: Eur Heart J Date: 2018-05-07 Impact factor: 35.855

9. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.

Authors: David M Kent; Robin Ruthazer; Christian Weimar; Jean-Louis Mas; Joaquín Serena; Shunichi Homma; Emanuele Di Angelantonio; Marco R Di Tullio; Jennifer S Lutz; Mitchell S V Elkind; John Griffith; Cheryl Jaigobin; Heinrich P Mattle; Patrik Michel; Marie-Louise Mono; Krassen Nedeltchev; Federica Papetti; David E Thaler
Journal: Neurology Date: 2013-07-17 Impact factor: 9.910

10. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.

Authors: Hassan Mir; Reed Alexander C Siemieniuk; Long Ge; Farid Foroutan; Michael Fralick; Talha Syed; Luciane Cruz Lopes; Ton Kuijpers; Jean-Louis Mas; Per O Vandvik; Thomas Agoritsas; Gordon H Guyatt
Journal: BMJ Open Date: 2018-07-25 Impact factor: 2.692

3 in total

1. [Heart and brain-two terms, one central problem : The stroke].

Authors: R Erbel; H-C Diener
Journal: Herz Date: 2019-06 Impact factor: 1.443

2. [Secondary stroke prevention after TIA or ischemic stroke].

Authors: Hans Christoph Diener; Georg Nickenig
Journal: Herz Date: 2021-04-29 Impact factor: 1.443

Review 3. Expert opinion paper on cardiac imaging after ischemic stroke.

Authors: Renate B Schnabel; Stephan Camen; Fabian Knebel; Andreas Hagendorff; Udo Bavendiek; Michael Böhm; Wolfram Doehner; Matthias Endres; Klaus Gröschel; Andreas Goette; Hagen B Huttner; Christoph Jensen; Paulus Kirchhof; Grigorios Korosoglou; Ulrich Laufs; Jan Liman; Caroline Morbach; Darius Günther Nabavi; Tobias Neumann-Haefelin; Waltraud Pfeilschifter; Sven Poli; Timolaos Rizos; Andreas Rolf; Joachim Röther; Wolf Rüdiger Schäbitz; Thorsten Steiner; Götz Thomalla; Rolf Wachter; Karl Georg Haeusler
Journal: Clin Res Cardiol Date: 2021-06-18 Impact factor: 5.460

3 in total